Rapid Antidepressant Effect of Ketamine in the Electroconvulsive Therapy Setting
- 1 September 2012
- journal article
- research article
- Published by Wolters Kluwer Health in The Journal of ECT
- Vol. 28 (3) , 157-161
Abstract
Objectives Studies now provide strong evidence that the N-methyl-D-aspartate receptor antagonist ketamine possesses rapidly acting antidepressant properties. This study aimed to determine if a low dose of ketamine could be used to expedite and augment the antidepressant effects of electroconvulsive therapy (ECT) treatments in patients experiencing a severe depressive episode. Materials and Methods Subjects with major depressive disorder or bipolar disorder referred for ECT treatment of a major depressive episode were randomized to receive thiopental alone or thiopental plus ketamine (0.5 mg/kg) for anesthesia before each ECT session. The Hamilton Depression Rating Scale (HDRS) was administered at baseline and at 24 to 72 hours after the first and sixth ECT sessions. Results Electroconvulsive therapy exerted a significant antidepressant effect in both groups (F2,24 = 14.35, P < 0.001). However, there was no significant group effect or group-by-time interaction on HDRS scores. In addition, post hoc analyses of the time effect on HDRS showed no significant HDRS reduction after the first ECT session for either group. Conclusions The results of this pilot study suggest that ketamine, at a dose of 0.5 mg/kg, given just before ECT, did not enhance the antidepressant effect of ECT. Interestingly, the results further suggest that the coadministration of ketamine with a barbiturate anesthetic and ECT may attenuate the immediate antidepressant effects of the N-methyl-D-aspartate antagonist.Keywords
This publication has 38 references indexed in Scilit:
- Onset and Early Behavioral Effects of Pharmacologically Different Antidepressants and Placebo in DepressionNeuropsychopharmacology, 2003
- Small-Dose Ketamine Improves the Postoperative State of Depressed PatientsAnesthesia & Analgesia, 2002
- Antidepressant effects of ketamine in depressed patientsBiological Psychiatry, 2000
- Activation of Glutamatergic Neurotransmission by Ketamine: A Novel Step in the Pathway from NMDA Receptor Blockade to Dopaminergic and Cognitive Disruptions Associated with the Prefrontal CortexThe Journal of Neuroscience, 1997
- Ketamine anesthesia in electroconvulsive therapy.1996
- Mechanism of Action of BarbituratesAnnual Review of Pharmacology and Toxicology, 1981
- ANESTHETICS AND ELECTROCONVULSIVE-THERAPY SEIZURE DURATION - IMPLICATIONS FOR THERAPY FROM A RAT MODEL1981
- Ketamine As an Anaesthetic for EctThe British Journal of Psychiatry, 1973
- Ketamine (“Ketalar”): A Safer Anaesthetic for ECTThe British Journal of Psychiatry, 1972
- Standardised assessment and recording of depressive symptoms.1969